Road Ahead For Orchid Pharma & Cipla's Partnership To Combat UTI I MD Manish Dhanuka Shares Outlook
6 months ago•NDTV Profit
Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India
6 months ago•Business Standard
Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
6 months ago•Business Standard
Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
6 months ago•Business Standard
Orchid Pharma join hands with Cipla to launch new antibiotic in India
6 months ago•Business Standard
Orchid Pharma - Enmetazobactam, First Indian NCE Gets U.S. FDA Nod: Systematix
10 months ago•Bloomberg Quint
Orchid Pharma - A Preferred Play On Import Substitution Opportunity: Systematix Initiates Coverage With A Buy
1 year ago•Bloomberg Quint